Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center and the University at Buffalo have developed an AI tool to assess lung cancer patients’ risk of postoperative complications.
The model combines clinical data, CT imaging and large language model-generated explanations to provide personalized risk estimates and clinician-adjustable summaries, according to an April 27 news release.
Researchers evaluated the tool using data from 3,094 patients who underwent surgery between 2009 and 2023. The model identified complications with 75-80% sensitivity, compared to about 45% for thoracic surgeons.
The top-performing version also achieved about 81% accuracy in distinguishing higher- from lower-risk patients while maintaining low false-positive rates.
The tool is designed to support surgical decision-making by integrating patient-specific data with clinician input and may be expanded to other specialties following further validation.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
